Delayed coverage of drug-eluting stents after interventional revascularisation of chronic total occlusions assessed by optical coherence tomography: the ALSTER-OCT-CTO registry.

AIMS Following percutaneous coronary interventions (PCI) for revascularisation of chronic total occlusions (CTO) patients are at increased risk for stent thrombosis (ST). Delayed drug-eluting stent (DES) coverage has previously been shown to be related to ST. Using optical coherence tomography (OCT), we tested the hypothesis that CTO-PCI is associated with delayed DES coverage compared to non-CTO lesions. METHODS AND RESULTS From 06/2010 to 11/2013, 105 patients (111 lesions) with clinically driven follow-up angiography after PCI with DES received an OCT analysis. Patients with successful CTO-PCI (19 patients/20 lesions, 6.5±2.1 months post PCI) were included in the CTO group, and patients with non-CTO lesions and total stent length >24 mm (28 patients/28 lesions, 4.9±2.2 months post PCI) were used as a control group. Struts were analysed by OCT (CTO vs. control, mean±SD): covered: 68.9±21.9% vs. 89.6±10.4%, p<0.001; uncovered apposed: 20.2±16.2% vs. 7.5±8.7%, p=0.001; uncovered malapposed: 10.9±10.3% vs. 2.9±2.6%, p<0.001. Neointimal thickness was 92.0±61.2 m vs. 109.3±39.2 m, p=0.033. No differences concerning different CTO-PCI approaches were found. CONCLUSIONS A significantly delayed DES coverage after CTO-PCI was observed. Given the known increased rate of ST following CTO-PCI and the known association between delayed DES coverage and ST, OCT may aid in determining the optimal duration of dual antiplatelet therapy after CTO-PCI.

[1]  Ryo Torii,et al.  Incomplete Stent Apposition Causes High Shear Flow Disturbances and Delay in Neointimal Coverage as a Function of Strut to Wall Detachment Distance: Implications for the Management of Incomplete Stent Apposition , 2014, Circulation. Cardiovascular interventions.

[2]  P. Serruys,et al.  Serial optical frequency domain imaging in STEMI patients: the follow-up report of TROFI study. , 2014, European heart journal cardiovascular Imaging.

[3]  R. Whitbourn,et al.  Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[4]  M. Joner,et al.  Randomized comparison of biolimus-eluting stents with biodegradable polymer versus everolimus-eluting stents with permanent polymer coatings assessed by optical coherence tomography , 2014, The International Journal of Cardiovascular Imaging.

[5]  M. Joner,et al.  Early vascular healing with rapid breakdown biodegradable polymer sirolimus-eluting versus durable polymer everolimus-eluting stents assessed by optical coherence tomography. , 2013, Cardiovascular revascularization medicine : including molecular interventions.

[6]  A. Lindsay,et al.  Increase in J-CTO lesion complexity score explains the disparity between recanalisation success and evolution of chronic total occlusion strategies: insights from a single-centre 10-year experience , 2013, Heart.

[7]  S. Garcia,et al.  Chronic Total Occlusions: Patient Selection and Overview of Advanced Techniques , 2013, Current Cardiology Reports.

[8]  G. Parodi,et al.  Predictors of reocclusion after successful drug-eluting stent-supported percutaneous coronary intervention of chronic total occlusion. , 2012, Journal of the American College of Cardiology.

[9]  S. Windecker,et al.  Very late stent thrombosis with newer drug-eluting stents: no longer an issue? , 2012, Revista espanola de cardiologia.

[10]  N. Bruining,et al.  Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures , 2012, European heart journal.

[11]  Michail I. Papafaklis,et al.  Recanalisation of chronic total coronary occlusions: 2012 consensus document from the EuroCTO club. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[12]  U. Landmesser,et al.  Optical Coherence Tomography Imaging: Novel Insights into the Vascular Response After Coronary Stent Implantation , 2012, Current Cardiovascular Imaging Reports.

[13]  Ajay K. Jain,et al.  Successful recanalization of chronic total occlusions is associated with improved long-term survival. , 2012, JACC. Cardiovascular interventions.

[14]  E. Brilakis,et al.  A percutaneous treatment algorithm for crossing coronary chronic total occlusions. , 2012, JACC. Cardiovascular interventions.

[15]  Akiko Maehara,et al.  Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. , 2012, Journal of the American College of Cardiology.

[16]  Subhash Banerjee,et al.  The retrograde approach to coronary artery chronic total occlusions , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[17]  Giuseppe Biondi-Zoccai,et al.  Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging. , 2012, JACC. Cardiovascular interventions.

[18]  G. Stone,et al.  Long-term outcome of percutaneous coronary intervention for chronic total occlusions. , 2011, JACC. Cardiovascular interventions.

[19]  P. Serruys,et al.  Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial , 2011, European heart journal.

[20]  G. Werner.  Tools & Techniques: the antegrade recanalisation technique for CTO. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[21]  Gary S. Mintz,et al.  Strut Coverage and Late Malapposition With Paclitaxel-Eluting Stents Compared With Bare Metal Stents in Acute Myocardial Infarction: Optical Coherence Tomography Substudy of the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial , 2011, Circulation.

[22]  N. Munce,et al.  Intravascular and extravascular microvessel formation in chronic total occlusions a micro-CT imaging study. , 2010, JACC. Cardiovascular imaging.

[23]  R. Virmani,et al.  The differences between neovascularization of chronic total occlusion and intraplaque angiogenesis. , 2010, JACC. Cardiovascular imaging.

[24]  T. Kume,et al.  Comparisons of Baseline Demographics, Clinical Presentation, and Long-Term Outcome Among Patients With Early, Late, and Very Late Stent Thrombosis of Sirolimus-Eluting Stents: Observations From the Registry of Stent Thrombosis for Review and Reevaluation (RESTART) , 2010, Circulation.

[25]  Giuseppe Biondi-Zoccai,et al.  Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. , 2010, JACC. Cardiovascular interventions.

[26]  Eloisa Arbustini,et al.  Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. , 2010, European heart journal.

[27]  Peter Jüni,et al.  Correlation of Intravascular Ultrasound Findings With Histopathological Analysis of Thrombus Aspirates in Patients With Very Late Drug-Eluting Stent Thrombosis , 2009, Circulation.

[28]  Michael Joner,et al.  Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[29]  R. Virmani,et al.  Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization , 2007, Circulation.

[30]  Hiromasa Otake,et al.  Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. , 2007, European heart journal.

[31]  Michael Joner,et al.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.

[32]  Seung‐Jung Park,et al.  Late Stent Malapposition After Drug-Eluting Stent Implantation: An Intravascular Ultrasound Analysis With Long-Term Follow-Up , 2006, Circulation.